ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°©»ó¼±Å¬¸®´Ð
-
[SCIE]
Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
Kim M*, Ahn J*, Song DE, Yoon JH, Kang HC, Lim DJ, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim BH
/ Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
/ (2021) Feb;71(2):427-433
/ 202102
-
[SCIE]
Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry
Ahn J, Jin M, Song E, Ryu YM, Song DE, Kim SY, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim WG
/ Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry
/ 2021 Jan;31(1):61-67
/ 202101
-
[SCIE]
Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
Ahn J, Jin M, Song E, Jeon MJ, Kim TY, Ryu JS, Kim WB, Shong YK, Han JM, Kim WG
/ Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
/ 2020 Dec;35(4):830-837
/ 202012
-
[SCIE]
Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
Ahn J, Jeon MJ, Song E, Kim TY, Kim WB, Shong YK, Kim WG
/ Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
/ 2020;35(1):115-121
/ 202000
-
[SCIE]
Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib
Ahn J, Song E, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ
/ Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib
/ 2020;92(1):71-76
/ 202000